Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: Prognosis and identification by 111indium-octreotide imaging

Cancer

Volumn 117, Issue 19, 2011, Pages 4506-4511

  Alexandru, Daniela ^a   Glantz, Michael J ^b   Kim, Lyndon ^c   Chamberlain, Marc C ^d   Bota, Daniela A ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

111indium ( 111In) octreotide scintigraphy; anaplastic meningioma; atypical meningioma; overall survival; pulmonary metastasis

Indexed keywords

HYDROXYUREA; OCTREOTIDE; PENTETREOTIDE IN 111; PTK 747; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VATALANIB;

ADULT; AGED; ARTICLE; BRAIN SCINTISCANNING; CANCER RESISTANCE; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG DOSE ESCALATION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; LUNG BIOPSY; LUNG METASTASIS; LUNG SCINTISCANNING; MALE; MENINGIOMA; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RETROSPECTIVE STUDY; STEREOTACTIC TREATMENT; SURVIVAL TIME; THORACOTOMY; WHOLE BODY SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIUM RADIOISOTOPES; LUNG NEOPLASMS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OCTREOTIDE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 80052950122     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26065     Document Type: Article

References (36)

1. Arena S, Barbieri F, Thellung S, et al. Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity. J Neurooncol. 2004; 66: 155-166. (Pubitemid 38258370)
2. Kaminski JM, Movsas B, King E, et al. Metastatic meningioma to the lung with multiple pleural metastases. Am J Clin Oncol. 2001; 24: 579-582. (Pubitemid 33131419)
3. Central Brain Tumor Registry of the United States (CBTRUS). CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2006. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2010.
4. Goldberg H,. Extraaxial brain tumors. In:, Atlas SV, ed. Magnetic Resonance Imaging of the Brain and Spine. 1st ed. New York: Raven Press; 1991: 327-378.
5. Nathoo N, Ugokwe K, Chang AS, et al. The role of 111indium-octreotide brain scintigraphy in the diagnosis of cranial, dural-based meningiomas. J Neurooncol. 2007; 81: 167-174. (Pubitemid 44963975)
6. Karasick JL, Mullan SF,. A survey of metastatic meningiomas. J Neurosurg. 1974; 40: 206-212.
7. Figueroa BE, Quint DJ, McKeever PE, Chandler WF,. Extracranial metastatic meningioma. Br J Radiol. 1999; 72: 513-516. (Pubitemid 29241595)
8. Baisden BL, Hamper UM, Ali SZ,. Metastatic meningioma in fine-needle aspiration (FNA) of the lung: cytomorphologic finding. Diagn Cytopathol. 1999; 20: 291-294. (Pubitemid 29205523)
9. Reubi JC, Maurer R, Klijn JG, et al. High incidence of somatostatin receptors in human meningiomas: biochemical characterization. J Clin Endocrinol Metab. 1986; 63: 433-438. (Pubitemid 16035694)
10. Patel YC,. Somatostatin and its receptor family. Front Neuroendocrinol. 1999; 20: 157-198. (Pubitemid 29362641)
11. Lamberts SWJ, de Herder WW, Hofland LJ,. Somatostatin analogs in the diagnosis and treatment of cancer. Trends Endocrinol Metab. 2002; 13: 451-457. (Pubitemid 36733940)
12. Susini C, Buscail L,. Rationale for the use of somatostatin analogs as antitumor agents. Ann Oncol. 2006; 17: 1733-1742. (Pubitemid 44884046)
13. Klutmann S, Bohuslavizki KH, Brenner W, et al. Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningioma. J Nucl Med. 1998; 39: 1913-1917. (Pubitemid 28518893)
14. Chamberlain MC, Glantz MJ, Fadul CE,. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology. 2007; 69: 969-973. (Pubitemid 47366049)
15. Macdonald D, Cascino T, Schold S Jr, Cairncross J,. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990; 8: 1277-1280. (Pubitemid 20195640)
16. Pasquier D, Bijmolt S, Veninga T, et al. Rare Cancer Network. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys. 2008; 71: 1388-1393.
17. Rockhill J, Mrugala M, Chamberlain MC,. Intracranial meningiomas: an overview of diagnosis and treatment. Neurosurg Focus. 2007; 23: E1.
18. Burger PC, Scheithauer BW,. Meningioma 2007: Tumors of the Central Nervous System. Washington, DC: Armed Forces Institute of Pathology; 2007: 331-362.
19. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ,. Meningiomas. In:, Kleihues P, Cavenee WK, eds. 2000 WHO Classification of Tumors. Tumors of the Nervous System. Lyon, France: IARC; 2000: 175-196.
20. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM,. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol. 1997; 21: 1455-1465. (Pubitemid 27528256)
21. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002; 61: 215-225; discussion 226-229. (Pubitemid 34212595)
22. Chamberlain MC, Tsao-Wei DD, Groshen S,. Temozolomide for treatment-resistant recurrent meningioma. Neurology. 2004; 62: 1210-1212. (Pubitemid 38456523)
23. Simpson D,. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957; 20: 22-39.
24. Ko K-W, Nam D-H, Kong D-S, Lee J II, Park K, Kim J-H,. Relationship between malignant subtypes of meningioma and clinical outcome. J Clin Neurosci. 2007; 14: 747-753. (Pubitemid 46907600)
25. Ohta M, Iwaki T, Kitamoto T, Takeshita I, Tateishi J, Fukui M,. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management. Cancer. 1994; 74: 3176-3189. (Pubitemid 24375075)
26. Kallio M, Sankila R, Hakulinen T, Jaaskelainen J,. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery. 1992; 31: 2-12.
27. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL,. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg. 1985; 62: 18-24. (Pubitemid 15199399)
28. Reubi JC, Lang W, Maurer R, Koper JW, Lamberts SW,. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res. 1987; 47: 5758-5764. (Pubitemid 18046777)
29. Patel YC, Greenwood MT, Warszynska A, Panetta R, Srikant CB,. All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. Biochem Biophys Res Commun. 1994; 198: 605-612. (Pubitemid 24178411)
30. Klutmann S, Bohuslavizki KH, Tietje N, et al. Clinical value of 24-hour delayed imaging in somatostatin receptor scintigraphy for meningioma. J Nucl Med. 1999; 40: 1246-1251. (Pubitemid 29385630)
31. Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM,. Epidemiology of intracranial meningioma. Neurosurgery. 2005; 57: 1088-1095; discussion 1088-1095.
32. Plachsinka A, Mikolajczak R, Maecke H, et al. Efficacy of 99mTc-EDDA/HYNIC-TOC scintigraphy in differential diagnosis of solitary pulmonary nodules. Cancer Biother Radiopharm. 2004; 19: 613-620. (Pubitemid 39546301)
33. Wang F, Wang Z, Yao W, Xie H, Xu J, Tian L,. Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging. J Nucl Med. 2007; 48: 1442-1448.
34. Alberg AJ, Brock MV, Samet JM,. Epidemiology of lung cancer: looking to the future. J Clin Oncol. 2005; 23: 3175-3185. (Pubitemid 46217457)
35. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC,. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer. 1999; 85: 2046-2056. (Pubitemid 29202781)
36. Enam SA, Abdulrauf S, Mehta B, Malik GM, Mahmood A,. Metastasis in meningioma. Acta Neurochir (Wien). 1996; 138: 1172-1177; discussion 1177-1178.